Our results are consistent with a recent study in which the authors demonstrated that SHP2 played a fundamental role in the initiation, progression, and metastasis of human epidermal growth factor receptor 2 (HER2)-positive and triple-negative breast cancers [40]. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.